"Estrogen-related dementia" refers to cognitive decline linked to reduced estrogen levels, primarily in postmenopausal women. Estrogen plays a critical role in brain functions like memory and cognition, potentially safeguarding against Alzheimer's disease and other forms of dementia by supporting synaptic activity, reducing beta-amyloid plaques, and promoting neuronal survival.
Following menopause, declining estrogen levels may heighten the risk of cognitive impairment. Hormone replacement therapy (HRT) has been explored as a potential strategy to counteract this decline, though its benefits and risks remain under scrutiny. A deeper understanding of how estrogen influences dementia can guide the development of targeted therapies aimed at preserving cognitive health, particularly in aging women.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States